Opexa Therapeutics (OPXA +12%) moves up today after disclosing that Nasdaq regulators earlier...

|About: Opexa Therapeutics, Inc. (OPXA)|By:, SA News Editor

Opexa Therapeutics (OPXA +12%) moves up today after disclosing that Nasdaq regulators earlier this week agreed to postpone a possible delisting until May 15 after it files its quarterly report for the three months ending March 31. According to its regulatory filing, OPXA was given 45 days to present a plan to regain compliance.